Home - Products - Others - Other Targets - 4-(METHYLAMINO)-3-NITROBENZOIC ACID

4-(METHYLAMINO)-3-NITROBENZOIC ACID

CAS No. 41263-74-5

4-(METHYLAMINO)-3-NITROBENZOIC ACID( 4-Methylamino-3-nitrobenzoic acid | 4-Methylamino-3-nitro-benzoic acid | Benzoic acid, 4-(methylamino)-3-nitro- )

Catalog No. M24375 CAS No. 41263-74-5

4-(METHYLAMINO)-3-NITROBENZOIC ACID is a chemical compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG 388 In Stock
500MG 642 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-(METHYLAMINO)-3-NITROBENZOIC ACID
  • Note
    Research use only, not for human use.
  • Brief Description
    4-(METHYLAMINO)-3-NITROBENZOIC ACID is a chemical compound.
  • Description
    4-(METHYLAMINO)-3-NITROBENZOIC ACID is a chemical compound.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    4-Methylamino-3-nitrobenzoic acid | 4-Methylamino-3-nitro-benzoic acid | Benzoic acid, 4-(methylamino)-3-nitro-
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    41263-74-5
  • Formula Weight
    196.16
  • Molecular Formula
    C8H8N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CNc(ccc(C(O)=O)c1)c1[N+]([O-])=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Interleukin-6 Recept...

    Interleukin-6 Receptor (partial)

  • Mafenide Acetate

    Mafenide Acetate is a sulfonamide-type medication??inhibits the enzyme carbonic anhydrase and is used as topical anti-infective especially in burn therapy.

  • SRI-42127

    SRI-42127 is a novel small molecule inhibitor of the RNA regulatory factor HuR, which inhibits tumor growth, attenuates glial activation in a lipopolysaccharide-induced neuroinflammation model, and reduces neuropathic pain after nerve injury by inhibiting the neuroinflammatory response.